U.S. market Closed. Opens in 1 day 4 hours 24 minutes

INBX | Inhibrx, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue1.80M2.18M7.12M12.81M9.09M7.50M7.95M6.67M
Cost of Revenue1.19M2.85M2.69M73.50M47.91M33.45M25.51M16.99M
Gross Profit609.00K-668.00K4.44M-60.69M-38.81M-25.95M-17.56M-10.32M
Operating Expenses219.83M131.29M83.69M80.25M52.81M37.01M27.68M18.56M
Selling, General & Admin29.38M21.12M12.36M6.84M9.02M4.65M2.61M1.57M
Research & Development191.64M110.19M71.44M73.50M47.91M33.45M25.51M16.99M
Other Operating ExpensesN/A-14.00K-106.00K-80.00K-4.12M68.00K24.00KN/A
Operating Income-219.22M-129.12M-76.56M-67.44M-43.71M-29.51M-19.73M-12.15M
Other Expenses / Income-20.50M-29.90M-5.20M-8.19M-6.79M-1.41M-2.10M-739.00K
Before Tax Income-239.72M-145.22M-81.77M-75.63M-50.50M-30.93M-21.83M-12.88M
Income Tax Expenses3.00K3.00K2.00K3.00K898.00K96.00K250.00K-4.62M
Net Income-241.36M-145.23M-81.77M-75.64M-51.40M-31.16M-19.44M-8.27M
Interest Expenses31.84M16.11M5.22M10.82M5.72M1.48M2.13MN/A
Basic Shares Outstanding47.13M40.11M38.01M25.26M36.55M27.08M28.79M36.55M
Diluted Shares Outstanding47.13M40.11M38.01M25.26M36.55M27.08M28.79M36.55M
EBITDA-206.69M-125.82M-76.56M-67.44M-42.60M-28.77M-19.30M-11.89M
EBITDA Margin-11,482.94%-5,776.72%-1,074.58%-526.57%-468.54%-383.59%-242.83%-178.39%
EBIT-209.52M-129.12M-76.55M-64.82M-44.78M-29.59M-17.07M-12.88M
EBIT Margin-11,639.89%-5,928.19%-1,074.39%-506.07%-492.50%-394.49%-214.67%-193.27%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙